You are here

SBIR TOPIC 096:Novel Biodegradable Stents for Neonatal Aortic Coarctation

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 268201600041C-2-0-0
Agency Tracking Number: N44HL160041
Amount: $2,997,541.00
Phase: Phase II
Program: SBIR
Solicitation Topic Code: NHLBI
Solicitation Number: N/A
Timeline
Solicitation Year: 2017
Award Year: 2018
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
480 ARSENAL ST, STE 4
Watertown, MA 02472-2805
United States
DUNS: 782603125
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 Lee Core
 (617) 393-4600
 lcore@480biomedical.com
Business Contact
 Lee Core
Phone: (617) 393-4600
Email: lcore@480biomedical.com
Research Institution
N/A
Abstract

Aortic coarctation is a common congenital heart condition that is usually recognized during the neonatal period early after birth The usual treatment is open surgery Non surgical catheter based stent therapy is not available to treat neonatal aortic coarctation because children outgrow commercially available metallic stents Absorbable stents might revolutionize the treatment of aortic coarctation in children especially in neonates Neonates require small delivery systems for relatively large nominal diameter implants which is technically challenging No commercial alternatives are available for off label medical use There is a considerable unmet need for a purpose built absorbable scaffold stent for neonatal aortic coarctation

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government